New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
09:06 EDTCICigna could divest VADBe business, says Credit Suisse
Credit Suisse believes Cigna could divest its Variable Annuity Death Benefit business, or VADBe, given the complexities of understanding the business and the constraint on valuation. The analyst believes an exit is increasingly likely given a recent transaction in the space, increased interest by buyers, and improved equity markets. The firm believes a divestiture would increase Cigna's multiple and reiterates its Outperform rating and $28 price target.
News For CI From The Last 14 Days
Check below for free stories on CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
06:32 EDTCIPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use